| Date Filed | Type | Description |
| 08/11/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/03/2023 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on PROKIDNEY CORP.|
Txns:
| Granted 48,128 options to buy
@ $10.56, valued at
$508.2k
|
|
| 06/28/2023 |
4
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Bought 130,000 shares
@ $29.5136, valued at
$3.8M
|
|
| 05/24/2023 |
4
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Bought 150,000 shares
@ $32.2496, valued at
$4.8M
|
|
| 05/17/2023 |
4
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Bought 160,388 shares
@ $33.5669, valued at
$5.4M
Bought 69,612 shares
@ $32.9411, valued at
$2.3M
|
|
| 05/15/2023 |
4
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Gifted 10,269 options to buy
@ $0
Gifted 10,269 options to buy
@ $0 |
|
| 05/15/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/10/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/15/2022 |
4
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Converted 493,750 shares
@ $0
Converted 428,420 shares
@ $0
Disposed of 462,031 shares
@ $0
Disposed of 350,000 shares
@ $0
Converted 49,375 options to buy
@ $0
Converted 42,842 options to buy
@ $0
Acquired 15,947 options to buy
@ $0
Acquired 16,012 options to buy
@ $0
Acquired 73,332 options to buy
@ $0 |
|
| 04/15/2022 |
4/A
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 1,719,074 options to buy
@ $0 |
|
| 04/15/2022 |
3/A
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 3/A on Royalty Pharma plc |
| 02/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/01/2022 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Bought 22,666,667 shares
@ $1.5, valued at
$34M
|
|
| 11/15/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/12/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/14/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2020 |
3
| Legorreta Pablo G. (CEO, Chairman of the Board) has filed a Form 3 on Royalty Pharma plc |
| 06/02/2020 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 14,103 options to buy
@ $17.55, valued at
$247.5k
|
|
| 05/15/2020 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/13/2020 |
4
| Legorreta Pablo G. (10% Owner) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 2,500,000 shares
@ $20, valued at
$50M
|
|
|